Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5690307 | Seminars in Nephrology | 2017 | 10 Pages |
Abstract
SummaryEncapsulating peritoneal sclerosis (EPS) is a rare but serious complication of peritoneal dialysis. In this review, we describe the clinical picture and histologic changes to the peritoneal membrane that are associated with EPS and provide an update on current diagnosis and management. We also discuss the recent studies that have suggested that the use of more biocompatible solutions containing lower concentrations of glucose degradation product that often are pH neutral in combination with a change in clinical practice (reducing glucose exposure and monitoring peritoneal membrane function) might ameliorate peritoneal degeneration, reduce the incidence of EPS, and minimize the severity of the disease.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Helen MRCP, Stanley MD, FRCP, Masaaki MD, PhD,